TGVAX
Price
$27.47
Change
-$0.26 (-0.94%)
Updated
Sep 6 closing price
VTIAX
Price
$32.84
Change
-$0.59 (-1.76%)
Updated
Sep 6 closing price
Ad is loading...

TGVAX vs VTIAX

Header iconTGVAX vs VTIAX Comparison
Open Charts TGVAX vs VTIAXBanner chart's image
Thornburg International Equity A
Price$27.47
Change-$0.26 (-0.94%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index Admiral
Price$32.84
Change-$0.59 (-1.76%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TGVAX vs VTIAX Comparison Chart
Loading...
VS
TGVAX vs. VTIAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGVAX is a Buy and VTIAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 453B vs. TGVAX (2.8B). VTIAX pays higher dividends than TGVAX: VTIAX (3.26) vs TGVAX (1.69). TGVAX was incepted earlier than VTIAX: TGVAX (26 years) vs VTIAX (14 years). TGVAX is a more actively managed with annual turnover of: 48.88 vs. VTIAX (4.00). VTIAX has a lower initial minimum investment than TGVAX: VTIAX (3000) vs TGVAX (5000). TGVAX annual gain was more profitable for investors over the last year : 21.11 vs. VTIAX (13.73). VTIAX (25.53) and TGVAX (25.30) have equivalent 5 years return.
TGVAXVTIAXTGVAX / VTIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years14 years-
Gain YTD15.4457.715200%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets2.8B453B1%
Annual Yield % from dividends1.693.2652%
Returns for 1 year21.1113.73154%
Returns for 3 years-3.60-4.5879%
Returns for 5 years25.3025.5399%
Returns for 10 years-2.6728.24-9%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORRF34.85-0.11
-0.31%
Orrstown Financial Services
DOW51.31-0.27
-0.52%
Dow
INDI3.84-0.06
-1.41%
indie Semiconductor
GKOS128.35-2.46
-1.88%
Glaukos Corp
XLO0.78-0.04
-4.83%
Xilio Therapeutics